GOSSGossamer Bio, Inc.

Nasdaq gossamerbio.com


$ 0.79 $ -0.02 (-1.99 %)    

Friday, 19-Apr-2024 15:59:47 EDT
QQQ $ 414.59 $ -8.60 (-2.03 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.47 (-0.9 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 0.7838
$ 0.85
$ 0.78 x 1,200
$ 0.79 x 1,200
$ 0.77 - $ 0.85
$ 0.45 - $ 1.88
768,484
na
123.01M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-05-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-17-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-03-2022 12-31-2021 10-K
10 11-08-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-26-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-11-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-24-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-22-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wedbush-assumes-gossamer-bio-at-outperform-announces-price-target-of-4

Wedbush analyst Laura Chico assumes Gossamer Bio (NASDAQ:GOSS) with a Outperform rating and announces Price Target of $4.

 piper-sandler-maintains-overweight-on-gossamer-bio-maintains-15-price-target

Piper Sandler analyst Yasmeen Rahimi maintains Gossamer Bio (NASDAQ:GOSS) with a Overweight and maintains $15 price target.

 goldman-sachs-maintains-buy-on-gossamer-bio-lowers-price-target-to-8

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $9 to $8.

 wedbush-reiterates-outperform-on-gossamer-bio-maintains-6-price-target

Wedbush analyst Andreas Argyrides reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $6 price target.

 hc-wainwright--co-reiterates-buy-on-gossamer-bio-maintains-10-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price ta...

 gossamer-bio-q4-eps-021-inline-cash-cash-equivalents-and-marketable-securities-of-2964m-is-expected-to-provide-cash-runway-into-the-first-half-of-2026

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which met the analyst consensus estimate. This is a 6...

 on-march-4-2024-gossamer-bio-received-letter-stating-that-it-has-regained-compliance-with-minimum-bid-price-requirement-for-continued-listing-on-nasdaq

https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1728117/000172811724000013/goss-20240304.htm

 hc-wainwright--co-maintains-buy-on-gossamer-bio-raises-price-target-to-10

HC Wainwright & Co. analyst Patrick Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and raises the price target...

 wedbush-reiterates-outperform-on-gossamer-bio-maintains-6-price-target

Wedbush analyst Andreas Argyrides reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $6 price target.

 why-lantheus-holdings-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma ann...

 gossamer-bio-and-2-other-stocks-under-1-insiders-are-buying

The Dow Jones closed higher by around 490 points on Tuesday. When insiders purchase or sell shares, it indicates their confiden...

 wedbush-maintains-outperform-on-gossamer-bio-raises-price-target-to-6

Wedbush analyst Andreas Argyrides maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $5...

 recap-gossamer-bio-q3-earnings
Recap: Gossamer Bio Q3 Earnings
11/09/2023 12:45:22

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION